A significant sex difference was reported again in 2014, with higher basal and meal-stimulated serum gastrin levels among females than males on long-term PPI therapy for gastroesophageal reflux disease (GERD), whereas such sex difference was not observed in healthy controls who were not on PPIs (Figure 2) [28]. Here, GAST is linked to gastroesophageal reflux disease.